Introduction
============

Multiple organ failure (MOF) is an evolving clinical syndrome triggered by various stimuli and may be a consequence of tissue hypoperfusion with cellular hypoxia, metabolic dysfunction, and impaired bioenergetic processes \[[@B1]\]. MOF is the main cause of morbidity and mortality in patients admitted to the intensive care unit (ICU) and is recognized as the final common pathway preceding death in critically ill patients \[[@B2]-[@B4]\]. Sepsis, a major public health problem, often progresses to MOF \[[@B2],[@B3]\], which is believed to increase markedly the risk of death in ICU patients \[[@B2],[@B3],[@B5]\].

A need exists to evaluate organ function better over time in ICU patients. The Sequential Organ Failure Assessment (SOFA) score \[[@B6]-[@B8]\] was developed as a tool to describe quantitatively the time course of organ dysfunction \[[@B9],[@B10]\]. Changes in SOFA score have been correlated with prognosis (delta SOFA and SOFA max) \[[@B8],[@B10]\] and are now widely used to assess the effects of therapeutic interventions \[[@B11],[@B12]\]. The aim of our study was to investigate the relation between the patterns of early changes in organ function in the ICU and outcome from critical illness. The study set up the hypothesis that recognition of early changes in organ function may characterize the clinical course of critically ill patients. Moreover, we explored the relative roles of sepsis and MOF in determining outcome in critically ill patients.

Materials and methods
=====================

This study is a subanalysis of the prospective, multicenter, observational study, the sepsis occurrence in acutely ill patients (SOAP) study, which was designed to create a database of ICU patients in European countries. Recruitment, data collection, and management are detailed elsewhere \[[@B2]\]; in brief, all patients older than 15 years admitted to the 198 participating centers (see the Acknowledgements for a list of participating countries and centers) between May 1 and May 15, 2002, were included. Patients who stayed in the ICU for less than 24 hours for routine postoperative observation were not included. Patients were followed up until death, hospital discharge, or for 60 days. Because the observational SOAP study did not require any deviation from routine medical practice, institutional review board approval was either waived or expedited in participating institutions, and informed consent was not required. As such, no supplementary review-board documents were needed for the current substudy.

Data were collected prospectively by using preprinted case-report forms. Data collection on admission included demographic data and comorbidities. Clinical and laboratory data for the simplified acute physiology score (SAPS) II \[[@B13]\] were reported as the worst value within 24 hours after admission. Microbiologic and clinical infections were reported daily, as well as the antibiotics administered. Organ function was evaluated on admission and daily thereafter, by using the SOFA score \[[@B6]\]. Data were encoded centrally in the organizing center by medical personnel (Department of Intensive Care, Erasme Hospital), and a number of quality control measures were carried out to assure consistency of the data and the quality of data entry \[[@B2]\]. All variables were defined *a priori*, and definitions were available on an Internet-based website throughout the study period.

Definitions
-----------

Sepsis syndromes were defined according to consensus conference definitions \[[@B14]\]. Organ failure was defined as a SOFA score \>2 for any of the six organs/systems evaluated, and MOF, as more than one failing organ \[[@B7]\]. An increase in the SOFA score of at least 1 point was considered as deterioration in organ function. SOFAmax was defined as the maximum SOFA score recorded during the ICU stay, and SOFAmean, as the mean value during the ICU stay. Individual organ failures during the ICU stay were defined according to the SOFAmax for the corresponding organ. Combinations of organ failures were considered independent of the time of onset of each organ failure. The delta SOFA (ΔSOFA) was calculated as the difference between the SOFA score on a specific day and the score on the day of admission to the ICU \[[@B8]\].

Statistical analysis
--------------------

For the purposes of this analysis, we excluded all patients who spent less than 48 hours in the ICU. To investigate the impact of sepsis on organ failure, patients were divided into three groups; Patients without sepsis, those in whom sepsis developed within 48 hours after ICU admission, and those in whom sepsis developed more than 48 hours after admission to the ICU.

Data were analyzed by using SPSS 13.0 for Windows (SPSS Inc., Chicago, IL, USA). Descriptive statistics were computed for all study variables. The Kolmogorov-Smirnov test was used to verify the normality of distribution of continuous variables. Nonparametric tests of comparison were used for variables evaluated as not normally distributed. Difference testing between groups was performed by using the two-tailed *t*test, Mann-Whitney *U*test, χ^2^test, and Fisher Exact test, as appropriate, with a Bonferroni correction for multiple comparisons. Differences in SOFA scores between groups over time were assessed by using multifactorial analysis of variance (ANOVA).

Continuous data are presented as mean ± SD, and categoric data, as number (%), unless otherwise indicated. All statistics were two-tailed, and a *P*\< 0.05 was considered to be statistically significant.

Results
=======

Characteristics of the study group
==================================

Of the 3,147 patients included in the SOAP database, 2,933 patients stayed in the ICU for more than 48 hours (Table [1](#T1){ref-type="table"}). The admission SOFA score for these patients was 5.0 ± 3.7; the maximum SOFA, 6.6 ± 4.4; and the mean SOFA, 5.0 ± 3.7. The median ICU length of stay was 3.4 (IQ, 2.0 to 7.6) days, and the median length of hospital stay, 16 (8 to 33) days. The overall ICU and hospital mortality rates were 16.6% and 21.9%, respectively.

###### 

Characteristics of the patients on ICU admission, lengths of ICU and hospital stays, and outcomes

  Number of patients                             2,933
  ---------------------------------------------- -----------------
  Age, years, median (IQ)^a^                     64 (50-74)
                                                 
  Sex, male/female, %                            61.5/38.5
                                                 
  Type of admission, n (%)                       
   Medical                                       1,584 (54.0)
   Surgical                                      1,349 (46.0)
   Elective                                      766 (26.1)
   Emergency                                     583 (19.9)
                                                 
  ICU admission source, n (%)^b^                 
   ER/ambulance                                  818 (27.9)
   Hospital floor                                726 (24.8)
   OR/recovery room                              765 (26.1)
   Other hospital                                332 (11.3)
                                                 
  Comorbidities, n (%)                           
   COPD                                          322 (11.0)
   Cancer                                        299 (10.2)
   Heart failure                                 287 (9.8)
   Diabetes                                      208 (7.1)
   Cirrhosis                                     115 (3.9)
   Hematologic cancer                            63 (2.1)
   HIV/AIDS                                      8 (0.3)
                                                 
  SAPS II score, mean ± SD                       35.9 ± 16.4
                                                 
  SOFA score, mean ± SD                          5.0 ± 3.7
                                                 
  Duration of ICU stay, days, median (IQ)        3.4 (2.0-7.6)
                                                 
  Duration of hospital stay, days, median (IQ)   16.0 (8.0-33.0)
                                                 
  ICU mortality, n (%)^c^                        486 (16.6)
                                                 
  Hospital mortality, n (%)^d^                   642 (21.9)

^a^Seven missing values; ^b^292 missing values; ^c^one missing value; ^d^44 missing values.

Patterns of organ failure and their relation to outcome
-------------------------------------------------------

On admission to the ICU, 1,675 (57.1%) patients had at least one organ failure; these patients had ICU and hospital mortality rates of 27.6% and 34.2%, respectively. In total, 435 (15%) patients developed organ failure in the ICU. The organ failures most commonly present on the day of admission to the ICU were of the cardiovascular (24%) and respiratory (22%) systems, whereas respiratory (43%) and renal (36%) organ failures were the most prevalent during the ICU stay (Table [2](#T2){ref-type="table"}). The combination of respiratory and cardiovascular organ failures was the most common on admission (9%) and during the ICU stay (25%).

###### 

ICU and hospital mortality rates according to the number, type, and combinations of failed organs

                                       On admission to the ICU   At any time during ICU stay                          
  ------------------------------------ ------------------------- ----------------------------- ---- ------------ ---- ----
  Number of failed organs                                                                                             
                                                                                                                      
   1                                   927 (32)                  17                            23   942 (32)     5    11
   2                                   524 (18)                  28                            37   677 (23)     24   33
   3                                   181 (6)                   45                            50   334 (11)     44   51
   \>3                                 43 (1)                    58                            70   157 (5)      73   79
                                                                                                                      
  Type of organ failure^a^                                                                                            
                                                                                                                      
   Cardiovascular                      717 (24)                  31                            39   993 (34)     35   41
   Respiratory                         653 (22)                  27                            33   1,258 (43)   29   36
   CNS                                 601 (21)                  32                            39   757 (26)     38   45
   Renal                               513 (18)                  26                            35   1,058 (36)   28   36
   Coagulation                         130 (18)                  36                            45   290 (10)     44   54
   Hepatic                             82 (3)                    33                            40   165 (6)      38   45
                                                                                                                      
  Combinations of two organ failures                                                                                  
                                                                                                                      
   Respiratory + cardiovascular        274 (9)                   39                            46   726 (25)     39   46
   Respiratory + renal                 120 (4)                   42                            49   543 (19)     41   48
   Respiratory + CNS                   197 (7)                   38                            47   488 (17)     43   50
   Hepatic + renal                     24 (1)                    38                            46   98 (3)       47   51
   Respiratory + hepatic               22 (1)                    50                            50   109 (4)      47   53
   Renal + cardiovascular              24 (1)                    38                            46   481 (16)     47   55
   CNS + cardiovascular                220 (8)                   39                            48   390 (13)     50   55
   CNS + renal                         109 (4)                   39                            51   308 (11)     49   57
   Hepatic + cardiovascular            29 (1)                    48                            52   97 (3)       55   59
   Respiratory + coagulation           34 (1)                    47                            53   203 (7)      53   63
   Coagulation + cardiovascular        51 (2)                    47                            59   201 (7)      56   65
   Coagulation + renal                 25 (1)                    52                            68   159 (5)      59   67
   Coagulation + hepatic               15 (1)                    67                            80   64 (2)       63   70
   Hepatic + CNS                       29 (1)                    58                            67   97 (3)       66   71
   Coagulation + CNS                   23 (1)                    65                            74   113 (4)      69   79

^a^Alone or in combination with other organs.

Hospital mortality rates increased according to the severity of organ dysfunction/failure as assessed by the SOFA score (Figure [1](#F1){ref-type="fig"}) and according to the number of failing organs (Table [2](#T2){ref-type="table"}). The highest hospital mortality rates were observed in patients with failure of the hepatic or coagulation systems, and in patients with combined coagulation and hepatic or coagulation and central nervous system (CNS) failure, mortality rates reached 70% to 80%.

![**Hospital mortality rates according to SOFA score on admission (gray columns) and the maximum SOFA score (black columns)**.](cc11868-1){#F1}

Early changes in organ failure and outcome
------------------------------------------

The time to achieve SOFAmax was longer in nonsurvivors than in survivors (2 (2 to 3) versus 1 (1 to 2) days; *P*\< 0.001). Patients who exhibited an improvement or no change in organ function over the first 24 hours after admission to the ICU had lower ICU and hospital mortality rates compared with those whose scores increased (12.4 and 18.4% versus 19.6 and 24.5%; *P*\< 0.05 pairwise). Likewise, patients who exhibited an improvement or no change in organ function over the second day in the ICU had lower ICU and hospital mortality rates compared with those whose scores increased (13.8 and 20.7% versus 18.6 and 24.1%; *P*\< 0.05 pairwise). Delta SOFA scores were higher and remained higher in nonsurvivors than in survivors over the first 4 days in the ICU; they decreased significantly over time in survivors (Figure [2](#F2){ref-type="fig"}).

![**Error bars representing the delta SOFA scores (mean ± 95% CI) during the first 4 days in the ICU in survivors (solid circles) and nonsurvivors (solid triangles) in the whole cohort (A) (*n*= 2,933) and in patients without (*n*= 1,789) (B), or with sepsis (*n*= 1,144) (C)**. \**P*\< 0.05 compared with ΔSOFA 24-0 (ANOVA with Bonferroni correction for multiple comparisons); †multifactorial ANOVA; *P*\< 0.05 compared with survivors.](cc11868-2){#F2}

Impact of sepsis on incidence and outcome from organ failure
============================================================

In total, 1,144 (39%) patients had sepsis at some point during the ICU stay, including 865 during the first 48 hours in the ICU and 279 after 48 hours. MOF occurred more frequently in patients with sepsis, irrespective of the time of onset (Table [3](#T3){ref-type="table"}). During the ICU stay, renal failure was the most common organ failure in patients who never had sepsis, and respiratory failure was the most common in patients with sepsis.

###### 

Incidence of organ failure according to the presence of sepsis

                                              **No sepsis (***n***= 1,789)**   Sepsis within 48 hours (*n*= 865)   Sepsis after 48 hours (*n*= 279)
  ------------------------------------------- -------------------------------- ----------------------------------- ----------------------------------
  Organ failure on admission to the ICU                                                                            
                                                                                                                   
  Number of failing organs, median (IQ)       0 (0-1)                          1 (0-2)^a^                          1 (0-2)^a^
  Any organ failure, *n*(%)                   874 (49)                         607 (70)^a^                         194 (70)^a^
   1                                          563 (32)                         271 (31)                            93 (33)
   2                                          228 (13)                         219 (25)^a^                         77 (28)^a^
   3                                          72 (4)                           87 (10)^a^                          22 (8)^a^
   \>3                                        11 (1)                           30 (3)^b^                           2 (1)
  Type of organ failure                                                                                            
   Respiratory                                320 (18)                         256 (30)^a^                         77 (28)^a^
   CNS                                        317 (18)                         199 (23)^a^                         85 (31)^a^
   Cardiovascular                             306 (17)                         320 (37)^a^                         91 (33)^a^
   Renal                                      258 (14)                         210 (24)^a^                         45 (16)
   Coagulation                                49 (3)                           69 (8)^a^                           12 (4)
   Hepatic                                    30 (2)                           41 (5)^a^                           11 (4)^b^
                                                                                                                   
  Organ failure at any time during ICU stay                                                                        
                                                                                                                   
  Number of failing organs, median (IQ)       1 (0-2)                          2 (1-3)                             2 (1-3)
  Any organ failure, *n*(%)                   1,120 (63)                       732 (85)^a^                         258 (92)^a^
   1                                          652 (36)                         230 (27)^a^                         60 (22)^a^
   2                                          307 (17)                         253 (29)^a^                         117 (42)^a^
   3                                          121 (7)                          158 (18)^a^                         55 (20)^a^
   \>3                                        40 (2)                           98 (11)^a^                          26 (9)^a^
  Type of organ failure                                                                                            
   Renal                                      559 (31)                         386 (45)^a^                         113 (41)^a^
   Respiratory                                514 (29)                         528 (61)^a^                         216 (77)^a^
   Cardiovascular                             406 (23)                         432 (50)^a^                         155 (56)^a^
   CNS                                        368 (21)                         270 (31)^a^                         119 (43)^a^
   Coagulation                                102 (6)                          143 (17)^a^                         45 (16)^a^
   Hepatic                                    49 (3)                           84 (10)^a^                          32 (12)^a^

CNS, central nervous system; IQ, interquartile range. ^b^*P*\< 0.05; ^a^*P*\< 0.01 compared with patients without sepsis (pairwise comparisons with Bonferroni correction for multiple comparisons).

ICU (24 and 28 versus 11%; *P*\< 0.001 each) and hospital mortality rates (33 and 33 versus 14%; *P*\< 0.001 each) were more than double in patients who had sepsis within or after 48 hours than in those who never had sepsis. Mortality from any type of organ failure was higher in patients with sepsis than in those who did not have sepsis, irrespective of the time of onset (Table [4](#T4){ref-type="table"}). Hospital mortality rates in patients with single-organ failure during the ICU stay were higher in patients with sepsis than in those who never had sepsis (sepsis within 48 hours and sepsis after 48 hours versus no sepsis: hospital mortality, 16 and 13 versus 9%, respectively; *P*\< 0.01 pairwise). However, patients with MOF had similar mortality rates regardless of whether they had sepsis (ICU mortality ranging from 23% to 76%, and hospital mortality ranging from 32% to 89%).

###### 

ICU and hospital mortality rates according to the number and type of failed organs and the presence of sepsis

                                    ICU mortality (%)   Hospital mortality                        
  --------------------------------- ------------------- -------------------- ------- ---- ------- -------
  On admission to the ICU                                                                         
  Any organ failure                 20                  30^a^                30^a^   25   40^a^   37^a^
   1                                13                  20^a^                30^a^   18   30^a^   36^a^
   2                                25                  30                   29      33   41^a^   38^a^
   3                                44                  48                   32      47   56      36
   \> 3                             55                  60                   50      64   73      50
  Type of organ failure                                                                           
   Respiratory                      10                  34^a^                31^a^   25   44^a^   36^a^
   CNS                              34                  32                   27^a^   38   42^b^   36^a^
   Cardiovascular                   25                  38^a^                28^b^   31   48^a^   33^a^
   Renal                            20                  32^a^                31^a^   26   44^a^   42^a^
   Coagulation                      22                  46^a^                33^b^   27   58^a^   50^b^
   Hepatic                          20                  34^a^                64^a^   28   42^a^   64^a^
                                                                                                  
  At any time during the ICU stay                                                                 
                                                                                                  
  Any organ failure                 17                  28^a^                30^a^   22   38^a^   37^a^
   1                                5                   6                    7       9    16^a^   13^a^
   2                                24                  23                   27      32   34      34
   3                                47                  43                   42      50   52      51
   \>3                              76                  71                   69      76   89      77
  Type of organ failure                                                                           
   Renal                            20                  38^a^                41^a^   26   50^a^   50^a^
   Respiratory                      24                  32^a^                32^a^   28   41^a^   40^a^
   Cardiovascular                   29                  40^a^                37^a^   33   49^a^   42^a^
   CNS                              36                  40^a^                39^a^   40   50^a^   46^a^
   Coagulation                      33                  49^a^                53^a^   41   60^a^   64^a^
   Hepatic                          27                  42^a^                47^a^   33   49^a^   50^a^

CNS, central nervous system; IQ, interquartile range. ^b^*P*\< 0.05; ^a^*P*\< 0.01 compared with patients without sepsis (pairwise comparisons with Bonferroni correction for multiple comparisons).

Delta SOFA scores over the first 4 days in the ICU were higher in nonsurvivors than in survivors, regardless of the presence of sepsis (Figure [2](#F2){ref-type="fig"}). SOFA scores remained elevated in survivors but decreased over time in survivors, irrespective of the presence of sepsis.

Discussion
==========

The main findings of our study were that (a) whatever the degree of organ failure at ICU admission, patients who exhibited an improvement or no change in organ function during the first 24 to 48 hours in the ICU had lower mortality rates than did those in whom organ function worsened; (b) in patients with single-organ failure during the ICU stay, hospital mortality was significantly greater in patients with sepsis than in those without; (c) patients with MOF had similar mortality rates, regardless of the presence of sepsis.

The association between early improvement in organ function and favorable prognosis has been reported in several other studies \[[@B8],[@B15],[@B16]\]. In 287 patients with severe sepsis, Russell *et al.*\[[@B15]\] reported that worsening of organ function over the first 3 days after the onset of sepsis syndrome was associated with higher 30-day mortality rates than was improvement or no change in organ function. In a study of 1,036 patients with severe sepsis, Levy *et al.*\[[@B16]\] also reported that early changes (baseline to day 1) in organ function were closely related to outcome. Interestingly, we found that the evolution of organ function on the second day in the ICU was associated with outcome, irrespective of the degree of organ function on admission to the ICU. These observations may help to identify patients in whom continuing therapy is likely to be futile \[[@B17]\], or to define patients who may benefit from a change in therapeutic strategy (for example, another surgical intervention, a change in antibiotic therapy, or more-intensive vasoactive support).

We found that the time required to achieve the highest degree of organ dysfunction/failure was shorter in survivors than in non-survivors. However, no specific pattern of organ failure was related to the presence of sepsis in our patients. Dulhunty *et al.*\[[@B18]\] reported that CNS dysfunction was more commonly present in patients with systemic inflammatory response syndrome (SIRS) but no infection and was associated more commonly with death in these patients than in those with sepsis. However, the assessment of neurologic failure using the GCS may be confounded by the frequent use of sedative agents in critically ill patients.

Several studies \[[@B3],[@B6],[@B16],[@B19]\] have investigated the epidemiology and outcome of sepsis-associated organ dysfunction/failure; however, studies in the nonsepsis population are scarce \[[@B4],[@B18]\]. Dulhunty *et al.*\[[@B18]\] investigated the time course of organ dysfunction and outcome in patients with severe sepsis and patients with severe noninfectious SIRS, but excluded all other patients, which may explain the higher ICU mortality rate of 25% in their noninfected population, compared with the 20% in our study. In our study, hospital mortality from single-organ failure during the ICU stay was greater in patients with sepsis than in those who never had sepsis; interestingly, mortality rates from MOF were similar, regardless of the presence of sepsis. In their large cohort of ICU patients in Australasia, Dulhunty *et al.*\[[@B18]\] reported similar findings.

Interestingly, the highest hospital mortality rates were observed in patients with failure of the hepatic or coagulation systems. Because disturbances of coagulation parameters are closely related with liver failure, this study highlights the enormous importance of liver function on the outcome of ICU patients. Umegaki *et al.*\[[@B20]\] also recently reported that hepatic dysfunction compared with other organ dysfunction was associated with the highest mortality rates in a study including 4,196 patients with severe sepsis.

A key strength of our study is the large database of patients and its multicenter, pan-European nature. The SOAP study was performed several years ago, but organ-dysfunction patterns are likely to change slowly over time, so these data are still relevant. Nevertheless, our study has some limitations. First, participation was on a voluntary basis. Second, our results can be extrapolated only to ICUs with a similar case-mix. Third, other factors, which were not considered in our report, may influence the outcome of MOF, including comorbidities, severity of illness, and local practice. We also did not discriminate between acute and chronic organ failure in our analysis.

Conclusions
===========

Although sepsis patients have worse outcomes than do nonsepsis patients, the differences are primarily in patients with only one organ failure, as the mortality in MOF is very high, regardless of the presence of sepsis. In all patients (with or without sepsis), changes in organ function during the first 24 to 48 hours after ICU admission can determine outcome, irrespective of the baseline degree of organ dysfunction. These patterns of organ failure and their relation to outcome may be useful in prognostication and, hence, in risk stratification of critically ill patients, including in the setting of clinical trials.

Key messages
============

• Whatever the degree of organ failure on admission to the ICU, patients who exhibited an improvement in organ function during the first 24 to 48 hours in the ICU had lower mortality rates than did the other patients.

• Higher mortality rates in sepsis compared with nonsepsis patients are primarily the result of higher mortality associated with single rather than multiorgan failure.

• Mortality rates in patients with multiorgan failure are high, irrespective of the presence of sepsis.

• Improved knowledge of patterns of organ failure and their relation to outcome may be useful in prognostication and, hence, in risk stratification of critically ill patients.
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